Corrigendum to "Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance"
- PMID: 34733355
- PMCID: PMC8559188
- DOI: 10.1177/17562864211049696
Corrigendum to "Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance"
Abstract
[This corrects the article DOI: 10.1177/17562864211001995.].
© The Author(s), 2021.
Erratum for
-
Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance.Ther Adv Neurol Disord. 2021 Mar 16;14:17562864211001995. doi: 10.1177/17562864211001995. eCollection 2021. Ther Adv Neurol Disord. 2021. PMID: 33796147 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
